Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Medical Electronic Systems released its new automated sperm quality analyzer, the SQA-Vision. Developed based on 10 years of market feedback, the SQA-Vision is positioned to augment Medical Electronic’s line of SQA-V and QwikCheck semen analyzers with a top-of-the-line solution.
The Diatron Group displayed its new walkaway clinical chemistry analyzer, the Pictus P500. This medium-throughput system (215 tests per hour on a typical sample mix) is ergonomically designed and user-friendly. The advanced, intuitive Windows-based software and smart architecture means the P500 offers many features on an accessible platform including uninterrupted workflow, enhanced walkaway operation, and remote-access diagnostics.
Festo displayed the EXCM mini H-gantry, its high-speed automated handling system for clinical laboratories. The planar surface gantry system is fast, accurate, modular, and flexible. This plug-and-play system can be used for dosing, barcode-based sample identification, liquid dispensing/pipetting with the addition of a Z-axis, and more. The desktop system moves vials on a planar X/Y axis with absolute positioning accuracy.
Nuclea Biotechnologies will begin offering more than 50 research-use-only mass spectrometry–based biomarker tests as part of its laboratory services. The tests detect and quantify protein biomarkers in human serum or plasma and are available to pharmaceutical companies for clinical trials, to researchers, and as companion diagnostics.
Swisslog Healthcare Solutions announced the launch of its Nexus Station. As the next generation of pneumatic tube stations, the Nexus Station provides quiet delivery of PTS carriers and improved carrier management through a carousel that handles both send and receive actions.
Diadexus and Mayo Clinic signed an agreement to collaborate in the areas of education, research, and innovation on the PLAC Test for Lp-PLA2 Activity. The FDA-cleared test is used to identify risk for coronary heart disease in patients with no history of cardiovascular events.
Beckman Coulter Diagnostics’ boothBeckman Coulter Diagnostics’ booth showcased its portfolio of high-productivity analytical and workflow systems. Solutions featured in the booth included the Power Express automation solution, the new DxH Connected Workcell, and IRIS International urinalysis solutions for automated urinalysis.
The Binding Site announced the formation of its new Immunologicals Group. Formerly known as OEM, this new team will have a broad remit to encompass the sales, marketing, and support of specialist antibodies, antigens, disease state sera, and services to IVD manufacturers, research scientists, and academic facilities.
BioMérieux announced the FDA 510(k) clearance and commercial availability of Vidas 3, the new generation of Vidas. Vidas 3 features enhanced automation, in particular the preanalytical section from the barcoded primary tube including dilution, improved traceability, and new software capabilities, as well as a quality control program in compliance with laboratory certification standards. Vidas 3 is CE marked and registered at the Chinese Food and Drug Administration.
EKF Diagnostics launched its Altair 240 clinical chemistry analyzerEKF Diagnostics launched its Altair 240 clinical chemistry analyzer, a benchtop platform that is EKF’s first fully integrated chemistry system for the global market. The fully automated system has LIS bidirectional connectivity, and double arm functionality yields up to 480 tests per hour.
